» Articles » PMID: 29457853

Mesenchymal-epithelial Transition of Pancreatic Cancer Cells at Perineural Invasion Sites is Induced by Schwann Cells

Overview
Journal Pathol Int
Specialty Pathology
Date 2018 Feb 20
PMID 29457853
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial-mesenchymal transition (EMT) promotes invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC). However, the importance of its reverse process, mesenchymal-epithelial transition (MET), for PDAC remains unclear. We aimed to characterize the histological finding "focal differentiation" in PDAC at perineural invasion sites in the context of MET and to investigate the role of Schwann cells in inducing tumor MET. Tumor differentiation and immunohistochemical expressions of E-cadherin, SMAD3, and vimentin at perineural invasion sites were examined in 168 PDAC tissues. Four PDAC cell lines were co-cultured with Schwann cells to investigate cell morphology, motility, or EMT-related markers using immunocytochemistry and quantitative PCR. Of 168 tumors, 124 (74%) showed focal differentiation with enhanced E-cadherin membrane expression (P < 0.001) and decreased nuclear accumulation of SMAD3 (P < 0.001). Among 115 PDACs harboring grade 1/2 tumor, tumors with focal differentiation showed worse survival compared to those without focal differentiation (P = 0.019). PDAC cells co-cultured with Schwann cells demonstrated a sheet-like appearance, increased E-cadherin expression, decreased expressions of SMAD3 and vimentin, and reduced cell motility. In conclusion, MET-like change is induced by Schwann cells, suggesting that Schwann cells contribute to PDAC colonization in pancreatic nerves through activating the MET machinery inside tumor cells in the pancreatic tumor microenvironment.

Citing Articles

Pancreatic cancer cells infiltrate nerves through TGFbeta1-driven perineural epithelial-to-mesenchymal-like transdifferentiation.

Krauss T, Gurcinar I, Bourquain U, Hieber M, Krohmer E, Wu N Neoplasia. 2025; 60:101126.

PMID: 39842382 PMC: 11763858. DOI: 10.1016/j.neo.2025.101126.


The Emerging Role of Schwann Cells in the Tumor Immune Microenvironment and Its Potential Clinical Application.

Zhang S, Chen J, Cheng F, Zheng F Int J Mol Sci. 2025; 25(24.

PMID: 39769484 PMC: 11679251. DOI: 10.3390/ijms252413722.


Quantitative Measurement of Perineural Invasion for Prognosis Analysis of Oral Cavity Cancer Treated by Radical Surgery With or Without Adjuvant Therapy.

Fan K, Kang C, Lin C, Ng S, Wang H, Hsieh C Technol Cancer Res Treat. 2023; 22:15330338231176366.

PMID: 37264638 PMC: 10272672. DOI: 10.1177/15330338231176366.


Melanoma-associated repair-like Schwann cells suppress anti-tumor T-cells via 12/15-LOX/COX2-associated eicosanoid production.

Kruglov O, Vats K, Soman V, Tyurin V, Tyurina Y, Wang J Oncoimmunology. 2023; 12(1):2192098.

PMID: 36998620 PMC: 10044150. DOI: 10.1080/2162402X.2023.2192098.


Schwann Cells in Digestive System Disorders.

Goluba K, Kunrade L, Riekstina U, Parfejevs V Cells. 2022; 11(5).

PMID: 35269454 PMC: 8908985. DOI: 10.3390/cells11050832.